Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Current Deferred Revenue (2019 - 2026)

Adagene (ADAG) posted quarterly Current Deferred Revenue of $3462.7 billion for Q4 2025, up 325.96% quarter-over-quarter from $812.9 billion in Q2 2023.

Analysis

Adagene (ADAG) Current Deferred Revenue (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Current Deferred Revenue for 6 consecutive years, with $3462.7 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Deferred Revenue changed N/A year-over-year to $3462.7 billion; the TTM figure through Dec 2025 stood at $3462.7 billion (changed N/A YoY), while the FY2025 annual figure was $3462.7 billion, changed N/A from the prior year.
  • Current Deferred Revenue climbed to $3462.7 billion in Q4 2025 per ADAG's latest filing, from $812.9 billion in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $20176.8 billion in Q2 2022 and bottomed at $5.5 million in Q4 2021.
  • Historically, Current Deferred Revenue has averaged $6593.3 billion across 4 years, with a median of $2137.8 billion in 2023.
  • Annual changes were most pronounced in 2022 — Current Deferred Revenue surged 274677645.45% — and 2023, when it slumped 95.97%.
  • Adagene's Current Deferred Revenue stood at $5.5 million in 2021, then soared by 274677645.45% to $15107.3 billion in 2022, then tumbled by 94.62% to $812.9 billion in 2023, then soared by 325.96% to $3462.7 billion in 2025.
  • Business Quant data shows ADAG's Current Deferred Revenue at $3462.7 billion in Q4 2025, $812.9 billion in Q2 2023, and $15107.3 billion in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.18 Mn
Dec 31, 2025 3.46 Mn
Jun 30, 2023 812,916.00
Dec 31, 2022 15.11 Mn
Jun 30, 2022 20.18 Mn
Dec 31, 2021 5.50 Mn
Jun 30, 2021 11.10 Mn
Dec 31, 2020 725,536.00
Dec 31, 2019 993,378.00